Picture of CareDx logo

CDNA — CareDx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

CareDx Inc expected to post a loss of 14 cents a share - Earnings Preview

* CareDx Inc  CDNA.OQ   CDNA.O  is expected to show a fall
in
quarterly revenue when it reports  results on July 31 for the
period ending June 30 2024
    * The Brisbane California California-based  company is
expected to
report a 3.5% decrease in revenue to $67.861 million from $70.3
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for CareDx Inc is for a loss
of 14
cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 7.3%
in the last three months. ​
    * Wall Street's median 12-month price target for CareDx Inc
is
$17.00​, below​ its last closing price of $18.72. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.22       -0.21      -0.03     Beat    85.4
 Dec. 31 2024  -0.27       -0.27      -0.17     Beat    36.2
 Sep. 30 2023  -0.40       -0.40      -0.18     Beat    54.5​
 Jun. 30 2023  -0.34       -0.31      -0.18     Beat    41.9
 ​​Mar.        -0.10       -0.11      -0.11     Met     -1.9
 31 2023                                                
 Jan. 1 0001   -0.08       -0.09      -0.07     Beat    18.8​
 Sep. 30 2022  -0.14       -0.14      -0.06     Beat    57.1
 Jan. 1 0001   -0.11       -0.11      -0.13     Missed  -16.1
 This summary was machine generated July 30 at 01:18 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on CareDx

See all news